Methylprednisolone Completed Phase 4 Trials for Acute Respiratory Distress Syndrome (ARDS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02819453Corticosteroid Mediates Acute Respiratory Distress Syndrome